Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.89 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.89 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.89 |
| ▸ | HPGD | P15428 | 5/20 | 0.89 |
| ▸ | MEN1 | O00255 | 4/20 | 0.89 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.89 |
| ▸ | RAB9A | P51151 | 6/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.78 |
| ▸ | NPC1 | O15118 | 4/20 | 0.78 |
| ▸ | AHR | P35869 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.49 |
| ▸ | GFER | P55789 | 1/20 | 0.47 |
| ▸ | NQO1 | P15559 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL483639 | 0.96 | MAPT (0.96) | MAPTKMT2AALDH1A1HPGDMEN1 | |
| SCHEMBL31261599 | 0.96 | MAPT (0.96) | MAPTKMT2AALDH1A1HPGDMEN1 | |
| Hydrochloric Acid SCHEMBL11439943 | 0.94 | MAPT (1.00) | MAPTKMT2AALDH1A1HPGDMEN1 | |
| SCHEMBL20209307 | 0.89 | KDM4E (0.69) | MAPTKMT2AALDH1A1HPGDMEN1 | |
| SCHEMBL257005 | 0.88 | MAPT (1.00) | MAPTKMT2AALDH1A1HPGDMEN1 | |
| SCHEMBL22301470 | 0.86 | ALDH1A1 (0.79) | MAPTKMT2AALDH1A1HPGDMEN1 | |
| SCHEMBL14174180 | 0.86 | KMT2A (0.79) | MAPTKMT2AALDH1A1HPGDMEN1 | |
| SCHEMBL136810 | 0.85 | KMT2A (0.73) | MAPTKMT2AALDH1A1HPGDMEN1 | |
| SCHEMBL16919496 | 0.85 | AHR (0.71) | MAPTKMT2AALDH1A1HPGDMEN1 | |
| SCHEMBL1547415 | 0.85 | KDM4E (0.75) | MAPTKMT2AALDH1A1HPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3423455-B1 | SEMICONDUCTING POLYMER | CLAP CO LTD (KR) | 2021-06-23 | — | — | EP | disclosed |
| EP-3551635-B1 | THIENO-INDENO-MONOMERS AND POLYMERS | BASF SE (DE) | 2021-04-28 | — | — | EP | disclosed |
| EP-3166949-B1 | THIENOTHIOPHENE-ISOINDIGO | CLAP CO LTD (KR) | 2021-02-17 | — | — | EP | disclosed |
| EP-3464415-B1 | SEMICONDUCTORS | BASF SE (DE) | 2020-08-19 | — | — | EP | disclosed |
| EP-3386989-B1 | NAPHTHOINDACENODITHIOPHENES AND POLYMERS | BASF SE (DE) | 2019-10-23 | — | — | EP | disclosed |
| WO-2018104367-A2 | THIENO-INDENO-MONOMERS AND POLYMERS | BASF SE (DE) | 2018-06-14 | — | — | WO | disclosed |
| WO-2017202635-A1 | SEMICONDUCTORS | BASF SE (DE) | 2017-11-30 | — | — | WO | disclosed |
| WO-2017097924-A1 | NAPHTHOINDACENODITHIOPHENES AND POLYMERS | BASF SE (DE) | 2017-06-15 | — | — | WO | disclosed |
| WO-2017089952-A1 | DEGRADABLE CONJUGATED POLYMERS | The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel (US) | 2017-06-01 | — | — | WO | disclosed |
| US-8334058-B2 | Emitters for systems which emit in dark blue; stable, significantly longer lifetime; can be sublimed well without decomposition; easier to process; more suitable for OLEDs; operating voltage, power efficiency remain unchanged at large layer thicknesses; important for production of full-colour displays | MERCK PATENT GMBH (DE) | 2012-12-18 | — | — | US | disclosed |
| US-20080145708-A1 | Compounds For Organic Electronic Devices | MERCK PATENT GMBH (DE) | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080145708-A1 | Compounds For Organic Electronic Devices | TYR, TOE1, GPX1 | MAPT 589/4885KMT2A 1816/4885ALDH1A1 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.